https://www.selleckchem.com/pr....oducts/eflornithine-
The glycosylation panel showed a weak correlation with clinical features, except for age. In addition, the results remained consistent when the subjects with prediabetes were excluded from the controls, and the adjusted ORs were 0.677, 0.738, 1.597, and 0.678 in the whole population. Furthermore, in the 13 rematched population, a significant association was observed, apart from GP20. The IgG glycosylation profile, reflecting an aging and pro-inflammatory status, was significantly associated with DR. The variat